Skip to main content
. 2020 Jun 6;12(6):1485. doi: 10.3390/cancers12061485

Table 3.

Survival outcomes.

OS DSS RFS LFS
T1a 21/22 (95.5%) 22/22 (100%) 21/22 (95.5%) 22/22 (100%)
T1b without AC involvement 5/5 (100.0%) 5/5 (100%) 4/5 (80.0%) 4/5 (80.0%)
T1b with AC
involvement
45/47 (95.7%) 45/47 (95.7%) 32/47 (68.1%) 37/47 (76.6%)
p-value 1.000 1.000 0.028 * 0.043 *

OS: overall survival; DSS: disease-specific survival; RFS: recurrence-free survival; LFS: laryngectomy-free survival; * p-value statistically significant.